Bhramara’s Prestigious Award for Distinguished Service to Humanity conferred on Covaxin-maker Mysore/Mysuru: Dr. Krishna Ella, Co-Founder and Executive Chairman of Bharat Biotech, Hyderabad, that invented Covaxin (the indigenous vaccine against COVID-19) has given a clarion call for the younger generation to take innovative steps so that a conducive atmosphere is created to check the next…
Dr. Krishna Ella stayed in Yadavagiri in Mysuru city during the 1980s. He was sent on Rotary Fellowship from Mysuru to study Master’s in the US which in a way contributed to the setting up of Bharat Biotech. Since Jan. 16, 2021, when India started administering the COVID-19 vaccine, there are several millions of people…
Dr. Krishna Ella, Co-Founder and Executive Chairman of Bharat Biotech, to receive the award in Mysuru on Mar. 4 Mysore/Mysuru: The science team of Bharat Biotech that developed the Covaxin vaccine has been selected to receive Bhramara’s Prestigious Award for Distinguished Service to Humanity instituted by the Bhramara Trust of Y.T. and Madhuri Thathachari, Mysuru….
Mysore/Mysuru: The Science team of Bharat Biotech that developed the Covaxin has been selected to receive Bhramara’s Prestigious Award for Distinguished Service to Humanity instituted by the Bhramara Trust of Y.T. and Madhuri Thathachari, Mysuru. “The Covaxin team of Bharat Biotech has made the whole country proud by developing this vaccine. Covaxin is the result…
New Delhi: Two Covid-19 vaccines —Covaxin by Bharat Biotech and Covishield by the Serum Institute of India — have received “conditional market authorisation” from India’s drug regulator, Union Health Ministry announced on Thursday. The approval was granted under the New Drugs and Clinical Trials Rules, 2019 after recommendations from the Subject Expert Committee (SEC) under…
New Delhi: The Government’s Subject Expert Committee (SEC) on Wednesday recommended granting regular market approval to Covishield and Covaxin Coronavirus vaccines, but with certain conditions. The Serum Institute of India (SII) and Bharat Biotech had submitted their respective applications to the country’s drug regulator, the Drugs Controller General of India (DCGI), seeking full market authorisation…
Mysore/Mysuru: Regular market approval to Covishield and Covaxin vaccines may not make much of a difference to Pharmacists as they are not trained in vaccination, said N. Raghavan, proprietor of Raghulal & Co., Mysuru. Speaking to Star of Mysore this morning regarding the Government’s Subject Expert Committee (SEC) recommending granting regular market approval to Covishield…
Over 12,000 teens jabbed in Mysuru as against a target of 10,000 New Delhi: Over 41 lakh children received the first dose of COVID-19 vaccines on Monday, the first day of the vaccination drive for those in the age group of 15-18 years, according to provisional data. While 41,27,468 doses of Covaxin were administered to…
High Schools, PU Colleges turn vaccination centres Mysore/Mysuru: Academic activities at High Schools and PU Colleges across Mysuru took a backseat this morning as the focus was on getting children aged between 15 and 18 vaccinated to stimulate the body’s immunity as a shield against infections unleashed by COVID-19 and its variants. All High Schools…
CM convenes meeting with experts tomorrow Bengaluru: The number of active COVID-19 cases in Karnataka, which had been consistently declining since September 2021, has breached the 10,000-mark again, for the first time since Oct. 10. Yesterday, the State reported 10 more cases of Omicron variant, taking the State’s Omicron tally to 76. The number of…
Cheluvamba Hospital to get Mobile NICUFebruary 20, 2024
A first in India: Snake bite is a ‘notifiable...February 20, 2024
Heritage Tonga rally promotes awareness on Co...February 20, 2024
Modification of school motto triggers fiery d...February 20, 2024
Recent Comments